The Boston Cancer Summit
Sanofi Genzyme, 500 Kendall St., Cambridge, MA

Luke Timmerman Seattle Registration 

Follow the news and you know: Scientists are more than just chipping away at cancer. They are kicking down the barricades. Cell therapies are, at long last, delivering lasting remissions in a few indications. Small molecules and antibodies with new mechanisms of action – sometimes in clever combination – are raising the bar, making cancer more of a chronic and tolerable disease. Underlying information on gene mutations, dysregulated protein networks and the tumor microenvironment provide a vivid glimpse of malignancy at the molecular level, and a wellspring for new therapeutic ideas. Much of this progress is occurring here in Massachusetts. Hear from the leaders in Big Pharma, venture capital, public biotech companies, and emerging startups at The Boston Cancer Summit, March 7. All proceeds go to the Mt. Everest Climb to Fight Cancer campaign at Fred Hutchinson Cancer Research Center. 

Confirmed speakers:

  • Bruce Booth, Partner, Atlas Venture
  • Jay Bradner, President, Novartis Institutes for Biomedical Research
  • Robert Urban, Global Head, Johnson & Johnson Innovation
  • David Berman, SVP, I-O Franchise Head, AstraZeneca/MedImmune
  • Barbara Weber, CEO, Tango Therapeutics
  • Garry Menzel, CEO, TCR2 Therapeutics
  • Nancy Simonian, CEO, Syros Pharmaceuticals
  • Jason Gardner, CEO, Magenta Therapeutics
  • Hugh O’Dowd, CEO, Neon Therapeutics
  • David Meeker, CEO, KSQ Therapeutics
  • Alexis Borisy, Partner, Third Rock Ventures
  • Kush Parmar, Managing Partner, 5AM Ventures
  • John Evans, Venture Partner, ARCH Venture Partners
  • Michael Gilman, CEO, Obsidian Therapeutics
  • Jo Lager, VP, Head of Development, Sanofi Oncology
  • Melanie Nallicheri, CBO, Foundation Medicine
  • Beth Trehu, CMO, Jounce Therapeutics
  • David Shaywitz, Senior Partner, Takeda Ventures
  • Kevin Conroy, CEO, Exact Sciences
  • Gary Nabel, Cheif Scientific Officer and Senior Vice President, Sanofi

Time: 1:00 PM - 6:00 PM

We're sorry, the deadline for buying tickets for this event has passed.


Return to Calendar